Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 5;59(41):18110-18115.
doi: 10.1002/anie.202006030. Epub 2020 Aug 18.

Stereoselective Synthesis of Tropanes via a 6π-Electrocyclic Ring-Opening/ Huisgen [3+2]-Cycloaddition Cascade of Monocyclopropanated Heterocycles

Affiliations

Stereoselective Synthesis of Tropanes via a 6π-Electrocyclic Ring-Opening/ Huisgen [3+2]-Cycloaddition Cascade of Monocyclopropanated Heterocycles

Carina M Sonnleitner et al. Angew Chem Int Ed Engl. .

Abstract

The synthesis of tropanes via a microwave-assisted, stereoselective 6π-electrocyclic ring-opening/ Huisgen [3+2]-cycloaddition cascade of cyclopropanated pyrrole and furan derivatives with electron-deficient dipolarophiles is demonstrated. Starting from furans or pyrroles, 8-aza- and 8-oxabicyclo[3.2.1]octanes are accessible in two steps in dia- and enantioselective pure form, being versatile building blocks for the synthesis of pharmaceutically relevant targets, especially for new cocaine analogues bearing various substituents at the C-6/C-7 positions of the tropane ring system. Moreover, the 2-azabicyclo[2.2.2]octane core (isoquinuclidines), being prominently represented in many natural and pharmaceutical products, is accessible via this approach.

Keywords: bicyclo[3.2.1]octanes; cocaine analogues; furans and pyrroles; isoquinuclidines; microwave-assisted [3+2]-cycloaddition; tropanes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Important representatives of biological active tropane and isoquinuclidine alkaloids.
Scheme 1
Scheme 1
Strategies to tropanes via cyclopropanated pyrroles and furans.
Scheme 2
Scheme 2
Substrate scope of [3+2]‐cycloadditions for the synthesis of 8‐azabicyclo[3.2.1]octanes 7: 0.3–1 mmol 4, dipolarophile (2.7 equiv); [a] Scale‐up: 4.39 mmol 4 a were employed to yield 1.54 g of 7 a; 4.03 mmol 4 b were employed to yield 1.15 g of 7 c; 4.18 mmol 4 c were employed to yield 1.18 g of 7 d; [b] 170 °C; [c] 100 °C; [d] 1 h, 1.1 equiv of dipolarophile; [e] Major diastereomer shown; [f] Combined isolated yield of two diastereomers; [g] Major regioisomer shown.
Scheme 3
Scheme 3
Substrate scope of [3+2]‐cycloadditions for the synthesis of 8‐oxabicyclo[3.2.1]octanes 8: 0.4–2.7 mmol 5, dipolarophile (2.7 equiv); [a] Scale‐up: 7.87 mmol (−)‐5 a were employed to yield 1.98 g of (+)‐8 a; [b] Major diastereomer shown. [c] Combined isolated yield of two diastereomers.
Scheme 4
Scheme 4
Stereochemical model for the [3+2]‐cycloaddition of 4 and 5.
Scheme 5
Scheme 5
Derivatization reactions of the 8‐oxabicyclo[3.2.1]octane framework 8 a,b. Conditions: 8 a: a) mCPBA (3.5 equiv), CH2Cl2, 50 °C, 18 h, 89 %; b) flash chromatography, 1 % triethylamine (TEA), 64 %; 8 b: c) TEA (1.3 equiv), CH2Cl2, 25 °C, 30 min, quant.
Scheme 6
Scheme 6
Derivatization reactions of the 8‐azabicyclo[3.2.1]octane framework 7 c and 7 f. Conditions: a) TEA (1.3 equiv), CH2Cl2, 2 h, 99 %; b) mCPBA (4.0 equiv), CH2Cl2, 25 °C, 3 days, 99 %; c) flash chromatography, 1 % TEA, 77 %; d) (i) NBS (2.0 equiv), acetone/H2O (3:1 v/v), 0 to 25 °C, 21 h; (ii) BzCl (1.5 equiv), DMAP (0.5 equiv), TEA (5.0 equiv), CH2Cl2, 25 °C, 8 h, 59 %; e) (i) TFA (33 equiv), CH2Cl2, 25 °C, 1.5 h, (ii) 37 % aq CH2O (6.0 equiv), NaBH3CN (3.0 equiv), MeCN, 25 °C, 1 h, 50 %; f) K2OsO4⋅2 H2O (0.05 equiv), NMO (2.0 equiv), H2O, acetone, 0 °C, 12 h, 43 %; g) RuCl3⋅3 H2O (6 mol %), NaIO4 (1.6 equiv), MeCN, H2O, 0 to 25 °C, 2 days, 47 %.
Scheme 7
Scheme 7
Isoquinuclidine synthesis by homoallylic radical rearrangement. Conditions: (a) (i) NBS (4.0 equiv), acetone/H2O (4:1 v/v), 0 to 25 °C, 3 days; (ii) BzCl (1.5 equiv), DMAP (0.5 equiv), TEA (5.0 equiv), CH2Cl2, 25 °C, 15 h, 43 %; (b) azobisisobutyronitrile (AIBN) (0.1 equiv), Bu3SnH (1.6 equiv), benzene, reflux, 5 h, 73 %; (c) (i) TFA (33 equiv), CH2Cl2, 25 °C, 1 h, (ii) 37 % aq CH2O (11 equiv), NaBH3CN (8.2 equiv), MeCN, 25 °C, 1.5 h, 61 %.
Scheme 8
Scheme 8
Base‐induced formation of 6‐azatricyclo[3.2.1.02, 7]octane 23 (a) and oxidative degradation of diacid 24 to 25 (b,c). Conditions: a) NaOH (2.0 equiv), THF, 0 to 25 °C, 5.5 h, then HCl, 0 °C, 98 %; b) (i) H2, Pd/C (10 mol %), EtOH/THF (1:4 v/v), 60 bar, 25 °C, 4 h, (ii) NaOH (2.0 equiv), THF, 0 to 25 °C, 4 h, then HCl, 0 °C, 95 %; c) Pb(OAc)4 (2.4 equiv), C5H5N, 67 °C, 6 h, 23 %.

References

    1. None
    1. Fodor G., Dharanipragada R., Nat. Prod. Rep. 1994, 11, 443; - PubMed
    1. O'Hagan D., Nat. Prod. Rep. 2000, 17, 435; - PubMed
    1. O'Hagan D., Nat. Prod. Rep. 1997, 14, 637.
    1. None

Publication types

LinkOut - more resources